Caricamento...
Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin
BACKGROUND: Breast cancer remains a major health problem worldwide, and is becoming increasingly resistant to traditional drug treatments. For instance, Adriamycin (ADR) is beneficial for the treatment of breast cancer. However, its wide application often leads to drug resistance in clinic practice,...
Salvato in:
| Pubblicato in: | BMC Complement Altern Med |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486132/ https://ncbi.nlm.nih.gov/pubmed/26066793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-015-0710-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|